This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Saw palmetto
DrugBank Accession Number
DB14360
Background

Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Approved, Experimental, Investigational
Synonyms
  • Abal Fructus
  • Brahea Serrulata Fruit
  • Chamaerops Serrulata Fruit
  • Corypha Obliqua Fruit
  • Corypha Repens Fruit
  • Diglossophyllum Serrulatum Fruit
  • Sabal Palm Fruit
  • Sabal Serrulata
  • Sabal Serrulata Fruit
  • Sabalis Serrulatae Fructus (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
  • Saw Palmetto Berry
  • Saw Palmetto Extract
  • Saw Palmetto Fruit
  • Saw Palmetto Fruit (Serenoa Repens (W. Bartram) Small (Sabal Serrulata (Michaux) Nichols))
  • Saw Palmetto Fruit Extract
  • Serenoa
  • Serenoa Preparation
  • Serenoa Repens Fruit
  • Serenoa Repens Fruit Dry Extract
  • Serenoa Repens Fruit Ethanol Extract
  • Serenoa Serrulata Fruit
  • Serenoa Serrulata Fruit Extract
  • Serenoa Serrulata Fruit Powder

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Ethical Herbals Urinary FlowCapsule160 mg / capOralAshbury Research CorporationNot applicableNot applicableCanada flag
SAMETTOCapsule320 mgOralบริษัท เมก้า ไลฟ์ไซแอ็นซ์ จำกัด (มหาชน)2008-03-31Not applicableThailand flag
Saw Palmetto Berries 500mgCapsule500 mgOralGeneral Nutrition Canada Inc.1999-12-172007-08-01Canada flag
Saw Palmetto Tincture - Liq 0.25 Gm/mlLiquid250 mg / mLOralHolista Health (Canada) Inc.1996-12-312001-08-01Canada flag
แบลคมอร์ส โปรเซอเรนCapsule160 mgOralบริษัท แบลคมอร์ส จำกัด2009-06-11Not applicableThailand flag
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-162017-10-16US flag
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-152017-10-15US flag
PROSTAGOOD PLUS KAPSÜL, 120 ADETSaw palmetto (160 mg) + Urtica dioica pollen (120 mg)CapsuleOralABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
PROSTAGOOD PLUS KAPSÜL, 60 ADETSaw palmetto (160 mg) + Urtica dioica pollen (120 mg)CapsuleOralABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş.2020-08-14Not applicableTurkey flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-162017-10-16US flag
Medi Megaton 2080Saw palmetto (0.01 g/100g) + Glycerin (0.002 g/100g) + Magnesium stearate (0.005 g/100g) + Silicon dioxide (0.01 g/100g) + Titanium dioxide (0.001 g/100g) + Zinc oxide (0.0146 g/100g)PowderTopicalMbg Inc (Korea Institute of Science Development)2016-10-152017-10-15US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
J7WWH9M8QS
CAS number
Not Available

References

General References
Not Available
RxNav
350488
Wikipedia
Serenoa

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedBasic ScienceBenign Prostatic Hyperplasia (BPH)1
4CompletedTreatmentBenign Prostatic Hyperplasia (BPH)1
4Unknown StatusTreatmentSexual Dysfunctions in Men With Benign Prostatic Hyperplasia1
3CompletedTreatmentBenign Prostatic Hyperplasia (BPH)1
3CompletedTreatmentUrological1
2CompletedTreatmentProstate Cancer1
1, 2CompletedTreatmentProstate Cancer1
Not AvailableUnknown StatusTreatmentAdrenergic Alpha-Antagonists / Prostatic Hyperplasia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral800 mg / cap
CapsuleOral160 mg / cap
PowderTopical
CapsuleOral
CapsuleOral
CapsuleOral320 mg
CapsuleOral500 mg
LiquidNot applicable1 kg/1kg
LiquidOral250 mg / mL
Capsule, coatedOral
CapsuleOral160 mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at July 05, 2018 17:13 / Updated at September 29, 2022 07:52